Neofect Balance Sheet Health
Financial Health criteria checks 5/6
Neofect has a total shareholder equity of ₩36.5B and total debt of ₩21.0B, which brings its debt-to-equity ratio to 57.5%. Its total assets and total liabilities are ₩71.2B and ₩34.7B respectively.
Key information
57.5%
Debt to equity ratio
₩21.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩21.21b |
| Equity | ₩36.51b |
| Total liabilities | ₩34.68b |
| Total assets | ₩71.19b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A290660's short term assets (₩33.7B) exceed its short term liabilities (₩22.8B).
Long Term Liabilities: A290660's short term assets (₩33.7B) exceed its long term liabilities (₩11.9B).
Debt to Equity History and Analysis
Debt Level: A290660 has more cash than its total debt.
Reducing Debt: A290660's debt to equity ratio has increased from 27.6% to 57.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A290660 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A290660 has sufficient cash runway for 2.6 years if free cash flow continues to grow at historical rates of 24.4% each year.